Latest filing: Analysts/Institutional Investor Meet/Con. Call Updates - Anthem Biosciences Limited
ObservedCompany dossier
Anthem Biosciences
NSE:ANTHEM · ISIN INE0CZ201020
- Close
- ₹790 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Anthem Biosciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 71.42% and public 28.58% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Anthem Biosciences Limited: Long-term rating upgraded to[ICRA]AA (Stable) from [ICRA]AA- (Positive); outlook revised to Stable from Positive; short-term rating reaffirmed; assigned for enhanced amount
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Anthem Biosciences Limited
NSE · conference call
Observed
Source filing Anthem Biosciences Ltd - 544449 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE · conference call
Observed
Source filing Shareholders meeting - Anthem Biosciences Limited
NSE · exchange filing
Observed
Source filing Anthem Biosciences Ltd - 544449 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 71.42%
- Public
- 28.58%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL